BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2605100)

  • 1. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
    Cowan RA; Harris M; Jones M; Crowther D
    Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA content and prognosis of non-Hodgkin's lymphoma.
    Morgan DR; Williamson JM; Quirke P; Clayden AD; Smith ME; O'Brien CJ; Allison DL; Child JA; Bird CC
    Br J Cancer; 1986 Oct; 54(4):643-9. PubMed ID: 3778806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
    De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
    Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic indicators in centroblastic-centrocytic lymphoma.
    Griffin NR; Howard MR; Quirke P; O'Brien CJ; Child JA; Bird CC
    J Clin Pathol; 1988 Aug; 41(8):866-70. PubMed ID: 3170773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.
    Wu HM
    J Tongji Med Univ; 1992; 12(2):65-70. PubMed ID: 1433420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
    Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
    Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma.
    Christensson B; Lindemalm C; Johansson B; Mellstedt H; Tribukait B; Biberfeld P
    Leuk Res; 1989; 13(4):307-14. PubMed ID: 2716347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
    Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
    Wooldridge TN; Grierson HL; Weisenburger DD; Armitage JO; Sanger WG; Collins MM; Pierson JL; Pauza ME; Fordyce R; Purtilo DT
    Cancer Res; 1988 Nov; 48(22):6608-13. PubMed ID: 3052808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
    Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
    Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
    Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
    Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency.
    McDunn SH; Winter JN; Variakojis D; Rademaker AW; Von Roenn JH; Tallman MS; Gordon LI; Bauer KD
    J Clin Oncol; 1991 Aug; 9(8):1334-40. PubMed ID: 1677032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.
    Joensuu H; Klemi PJ; Jalkanen S
    Cancer; 1990 Jun; 65(11):2564-71. PubMed ID: 2337874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA flow cytometry of non-Hodgkin's lymphomas: correlation with cytologic grade and clinical relapse.
    Saikia UN; Dey P; Vohra H; Gupta SK
    Diagn Cytopathol; 2000 Mar; 22(3):152-6. PubMed ID: 10679994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA ploidy, proliferative activities, and immunophenotype of malignant lymphoma: application of flow cytometry.
    Horii A; Yoshida J; Hattori K; Honjo Y; Mitani K; Takashima S; Sakai M; Okamoto S; Kubo T
    Head Neck; 1998 Aug; 20(5):392-8. PubMed ID: 9663666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
    Cowan RA; Jones M; Harris M; Steward WP; Radford JA; Wagstaff J; Deakin DP; Crowther D
    Br J Cancer; 1989 Feb; 59(2):276-82. PubMed ID: 2930692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of DNA ploidy and proliferative activity in Hodgkin's disease.
    Joensuu H; Klemi PJ; Korkeila E
    Am J Clin Pathol; 1988 Dec; 90(6):670-3. PubMed ID: 3195496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.